ACTEMRA Co-pay Program
Genentech, Inc. (Roche) · Actemra
Patient pays: as little as $0 per treatment
commercial insurance
How to apply: online or phone
Every Actemra assistance program you may qualify for - manufacturer and foundation programs, not a discount card. About a minute, no login.
Every Actemra program linked to its official source, with the date we checked it - rules, income limits, and application links included.
Tell us five things. We’ll do the rest.
Actemra (tocilizumab) is an il-6 receptor antagonist (biologic) made by Roche / Genentech. It is commonly prescribed for: Rheumatoid arthritis, Giant cell arteritis, Systemic juvenile idiopathic arthritis, Polyarticular juvenile idiopathic arthritis, Cytokine release syndrome, COVID-19 in hospitalized adults, Systemic sclerosis-associated ILD. Without financial assistance, Actemra typically costs around $4,500 per month.
Income limits
1 of the 2 active Actemra assistance programs we track caps household income. The lowest cutoff is $150,000 a year for a single person.
The Genentech Patient Foundation - Actemra uses dollar income limits instead: $150,000 for households of up to 4 people, plus $25,000 for each additional member.
Each program makes the final eligibility decision - confirm on the official application linked above.
Actemra offers more than one kind of program, and they have opposite rules:
We show both programs, and the real income limits, below. Or read the full copay card vs patient assistance guide
This is the full list before we filter by your situation. Use the calculator above to see only the ones you may qualify for.
Genentech, Inc. (Roche) · Actemra
Patient pays: as little as $0 per treatment
commercial insurance
How to apply: online or phone
Genentech, Inc. (Roche) · Actemra
uninsured · underinsured
How to apply: online or phone
Your prescriber signs part of the form.
Yes. Genentech, Inc. (Roche) runs the Genentech Patient Foundation - Actemra, which provides Actemra free of charge to eligible patients. The full rules and the official application link are in the program list above.
Medicare coverage for Actemra depends on your own plan: depending on how it is given, a drug can fall under Part B (administered in a clinic) or Part D (filled at a pharmacy), and each plan decides what it covers. Your plan's documents or Medicare's plan finder are the only reliable check. Separate from coverage, none of the Actemra assistance programs we track currently accept Medicare patients.
Yes - the ACTEMRA Co-pay Program from Genentech, Inc. (Roche). Eligible patients pay as little as $0 per treatment. It works for patients with commercial (private) insurance. Patients on Medicare or Medicaid cannot use the card itself. If you searched for an Actemra coupon, this manufacturer card is the official version of it.
Without insurance or assistance, Actemra typically costs around $4,500 per month in the US. The Genentech Patient Foundation - Actemra above can bring that down substantially for eligible patients - use the calculator to check your situation.
The official application form for the Genentech Patient Foundation - Actemra is on actemra.com - the application links on this page go straight to the program's own form. Some programs call it an enrollment form; it is the same document. Applying is always free; never pay a third-party service to file a patient assistance form for you.
None of the Actemra programs we track currently accept Medicare or Medicaid. If that changes, we will update this page.
Manufacturers like Roche / Genentech use "patient support program" as an umbrella term for nurse lines, insurance navigation, and financial help. The financial help is what we track here - for Actemra that is the Genentech Patient Foundation - Actemra. The support phone line is listed on the official program site linked above.